These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 14808729)

  • 41. Effect of fibrinolysin on the coagulability of fibrinogen.
    TRIANTAPHYLLOPOULOS DC; GREENE TL; TRIANTAPHYLLOPOULOS E
    Thromb Diath Haemorrh; 1962 Jul; 7():421-31. PubMed ID: 13922452
    [No Abstract]   [Full Text] [Related]  

  • 42. EFFECT OF PLASMIN ON FIBRINOGEN AND FIBRIN.
    GAJEWSKI J; ALEXANDER B
    Am J Physiol; 1964 Jan; 206():79-82. PubMed ID: 14111457
    [No Abstract]   [Full Text] [Related]  

  • 43. Transformation of fibrinogen into fibrin. II. Changes in pH during clotting of fibrinogen.
    MIHALYI E
    J Biol Chem; 1954 Aug; 209(2):733-41. PubMed ID: 13192127
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibition by acrizane chloride of the clotting of fibrinogen and the coagulase of Staphylococcus aureus.
    MILLER JM; JACKSON DA; COLLIER CS
    Antibiot Chemother (Northfield); 1959 Nov; 9():672-4. PubMed ID: 14422543
    [No Abstract]   [Full Text] [Related]  

  • 45. Studies on afibrinogenemia. II. The defibrinating effect on dog blood of intravenous injection of thromboplastic material.
    RATNOFF OD; CONLEY CL
    Bull Johns Hopkins Hosp; 1951 May; 88(5):414-24. PubMed ID: 14830934
    [No Abstract]   [Full Text] [Related]  

  • 46. [On the effect of protein inhibitor preparations (liver and parotid inhibitor) on extravasal fibrinolysis, fibrinogenolysis and blood coagulation constants in human blood].
    MARX R; CLEMENTE P; WERLE E; APPEL W
    Blut; 1963 May; 9():164-81. PubMed ID: 13933229
    [No Abstract]   [Full Text] [Related]  

  • 47. [Fibrinogen B and prethrombotic state].
    MALAGAMBA G; OTTAGGIO G
    Minerva Ginecol; 1952 Oct; 4(14):84-6. PubMed ID: 13024919
    [No Abstract]   [Full Text] [Related]  

  • 48. [The effect, in the presence and absence of ionized calcium, of certain antagonists of the thrombin conversion of fibrinogen].
    BURSTEIN M
    Arch Int Pharmacodyn Ther; 1951 Feb; 85(3-4):467-73. PubMed ID: 14830360
    [No Abstract]   [Full Text] [Related]  

  • 49. The inhibition by dequadin chloride of the clotting of fibrinogen and the coagulase of Staphylococcus aureus.
    MILLER JM; JACKSON DA; COLLIER CS
    Antibiot Chemother (Northfield); 1960 Jan; 10():46-9. PubMed ID: 14422545
    [No Abstract]   [Full Text] [Related]  

  • 50. [ON THE EFFECT OF SERUM AND PLASMA FACTORS OF NORMAL BLOOD ON THE SPREADING OF THROMBOCYTES].
    MARX R
    Klin Wochenschr; 1964 Jul; 42():650. PubMed ID: 14248617
    [No Abstract]   [Full Text] [Related]  

  • 51. Relationship of fibrinogen B to thromboembolic phenomena.
    RYAN EA
    Can Med Assoc J; 1951 Mar; 64(3):237-40. PubMed ID: 14801758
    [No Abstract]   [Full Text] [Related]  

  • 52. The inhibition by 9-aminoacridine of the clotting of fibrinogen by thrombin and the coagulase of the Staphylococcus aureus.
    MILLER JM; JACKSON DA; COLLIER CS
    Exp Med Surg; 1959; 17():177-80. PubMed ID: 14422544
    [No Abstract]   [Full Text] [Related]  

  • 53. [METHOD OFSTUDY OF BLOOD COAGULATION BASED ON THE CHANGES IN ELECTRIC RESISTANCE OF THE FIBRINNETWORK].
    BAYOBAYO JM; ZULUAGAJARAMILLO E
    Arch Inst Farmacol Exp (Madr); 1963; 15():75-93. PubMed ID: 14049389
    [No Abstract]   [Full Text] [Related]  

  • 54. Action of poly-alpha-amino acids on clotting of fibrinogen by thrombin.
    SHAFRIR E; DE VRIES A; KATCHALSKI E
    Proc Soc Exp Biol Med; 1954 Oct; 87(1):63-7. PubMed ID: 13224678
    [No Abstract]   [Full Text] [Related]  

  • 55. [THE PLASMATIC FACTOR OF THE SURFACE COAGULATIVE ACTIVITY OF STAPHYLOCOCCUS].
    GELOSA L
    Boll Ist Sieroter Milan; 1964; 43():188-96. PubMed ID: 14168463
    [No Abstract]   [Full Text] [Related]  

  • 56. Clot density determination of fibrinogen in experimental myocardial infarction.
    VOLK BW; LOSNER S; CRASTNOPOL P
    Proc Soc Exp Biol Med; 1955 Jun; 89(2):277-8. PubMed ID: 14395291
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on afibrinogenemia. I. Afibrinogenemia in a patient with septic abortion, acute yellow atrophy of the liver and bacteremia due to E. coli.
    CONLEY CL; RATNOFF OD; HARTMANN RC
    Bull Johns Hopkins Hosp; 1951 May; 88(5):402-13. PubMed ID: 14830933
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical value of the Lyons test in patients subjected to surgical intervention].
    ROSTI P; GRUGNI C
    Rass Int Clin Ter; 1953 Jun; 33(11):333-42. PubMed ID: 13100694
    [No Abstract]   [Full Text] [Related]  

  • 59. [A SIMPLE MODIFICATION OF THE 1-STEP PROCEDURE FOR DETERMINATION OF THROMBIN TIME, QUANTITY OF FIBRINOGEN AND FIBRINOLYTIC ACTIVITY OF THE BLOOD].
    KUZNIK BI
    Vopr Med Khim; 1964; 10():316-8. PubMed ID: 14221560
    [No Abstract]   [Full Text] [Related]  

  • 60. BLOOD LOSS ASSOCIATED WITH ADMINISTRATION OF LOW MOLECULAR WEIGHT DEXTRAN.
    GARZON AA; FINK LH; SHAFTAN GW; KARLSON KE
    J Thorac Cardiovasc Surg; 1964 Dec; 48():873-80. PubMed ID: 14239975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.